IBTA241018C60000
- 6.20
- +0.20+3.33%
Ibotta Newsroom
Ibotta Analyst Ratings
Goldman Sachs Upgrades Ibotta(IBTA.US) to Buy Rating, Cuts Target Price to $87
BofA Securities Maintains Ibotta(IBTA.US) With Buy Rating, Maintains Target Price $110
BofA Securities Maintains Ibotta(IBTA.US) With Buy Rating, Maintains Target Price $110
Ibotta, Inc.: A Buy Rating Amid Grocery Inflation and Digital Promotion Strengths
UBS Adjusts Price Target on Ibotta to $90 From $129, Maintains Buy Rating
A Quick Look at Today's Ratings for Ibotta(IBTA.US), With a Forecast Between $85 to $114
Press Release: CORRECTION -- Ibotta Reports Second Quarter 2024 Financial Results
Raymond James Maintains Outperform on Ibotta, Lowers Price Target to $75
A Quick Look at Today's Ratings for Ibotta(IBTA.US), With a Forecast Between $85 to $114
Ibotta Price Target Cut to $114.00/Share From $125.00 by Evercore ISI Group
Ibotta, Inc. Class A (IBTA) Receives a Buy From Evercore ISI
Analysts' Opinions Are Mixed on These NA Stocks: Loar Holdings Inc. (LOAR) and Ibotta, Inc. Class A (IBTA)
Ibotta Analyst Ratings
Needham Maintains Buy on Ibotta, Lowers Price Target to $100
JMP Securities Keeps Their Buy Rating on Ibotta, Inc. Class A (IBTA)
Analysts Have Conflicting Sentiments on These NA Companies: Nuveen Churchill Direct Lending Corp. (NCDL), Ibotta, Inc. Class A (IBTA) and BrightSpring Health Services, Inc. (BTSG)
Wells Fargo Adjusts Price Target on Ibotta to $105 From $131, Maintains Overweight Rating
Ibotta Analyst Ratings
Wells Fargo Maintains Overweight on Ibotta, Lowers Price Target to $105